Montz Harcus Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Montz Harcus Wealth Management's ABBV Position: Q2 2026 in Review
Montz Harcus Wealth Management reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $16.6K and leaving 2,937 shares worth $739K. The position accounts for 0.26% of the portfolio, ranked #38.
Montz Harcus Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Montz Harcus Wealth Management held 2,937 shares of AbbVie worth $739K as of Q2 2026.
- Montz Harcus Wealth Management sold 77 AbbVie shares in Q2 2026, an estimated $16.6K.
- AbbVie made up 0.26% of Montz Harcus Wealth Management's portfolio in Q2 2026, its #38 holding.
- Montz Harcus Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Montz Harcus Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.